CAGRILINTIDE

Overview:

Cagrilintide is a synthetic amylin analog specifically designed for advanced preclinical research studies focused on metabolic disorders and glucose regulation. This peptide provides researchers with a valuable tool to study amylin’s role in glucose homeostasis and appetite regulation, offering important insights into metabolic conditions such as diabetes and obesity.

Product Specifications:

• Purity: >99% (HPLC verified)
• Formulation: Lyophilized powder, optimized for reconstitution
• Molecular Formula: C₁₉₄H₃₁₂N₅₄O₅₉S₂
• Molecular Weight: ~4500 g/mol
• CAS Number: 1415456-99-3
• PubChem CID: 167312356

Cagrilintide is widely utilized in preclinical research models investigating the following areas:

• Amylin and Blood Glucose Regulation:
  Investigating how amylin affects glucose homeostasis in research models, with a focus on maintaining balanced glucose levels after meals.
• Amylin and Insulin Interactions:
  Studying the interaction between amylin and insulin in regulating glucose levels, critical for research on metabolic disorders such as diabetes.
• Metabolic Disorder Research:
  Exploring how amylin analogs like Cagrilintide influence glucose metabolism, relevant for studying potential strategies for managing metabolic dysfunction.
• Obesity Research:
  Investigating the role of amylin analogs in appetite regulation and energy balance, contributing to studies on obesity and weight management in research models.

Key Features:

• Precise Amylin Mimic:
  Cagrilintide closely mimics the function of human amylin, providing a precise model for researchers studying its effects on glucose regulation and satiety control in laboratory settings.
• Essential for Metabolic Research:
  Ideal for comprehensive studies focused on glucose homeostasis, appetite regulation, and metabolic disorders.
• Guaranteed Quality:
  Each batch of Cagrilintide undergoes rigorous testing to ensure high purity and reliability, supporting accurate and reproducible research outcomes.

For Research Use Only:

This product is strictly intended for research purposes only and is not approved for human or veterinary use. Cagrilintide must be handled exclusively by qualified professionals in controlled research environments. Bodily introduction into humans or animals is strictly prohibited by law. Please adhere to all applicable institutional guidelines and regulatory requirements when handling and using this product.